Showing results (161-170 of 196) with videos related to

Sort By:
Pageof 20
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivationMaria Jose Lista, Pedro M Matos, Thomas J A Maguire, et al.
The Lancet. Respiratory Medicine|May 9, 2021
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entityMarcin F Osuchowski, Martin S Winkler, Tomasz Skirecki, et al.
ERJ Open Research|July 16, 2024
Long-term impact of COVID-19 hospitalisation among individuals with pre-existing airway diseases in the UK: a multicentre, longitudinal cohort study - PHOSP-COVIDOmer Elneima, John R Hurst, Carlos Echevarria, et al.
Nature Communications|September 19, 2024
Shared neutrophil and T cell dysfunction is accompanied by a distinct interferon signature during severe febrile illnesses in childrenHarsita Patel, Michael J Carter, Heather Jackson, et al.
Nature Microbiology|October 27, 2020
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humansJeffrey Seow, Carl Graham, Blair Merrick, et al.
Intensive Care Medicine|April 11, 2018
Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)Tobias Welte, R Phillip Dellinger, Henning Ebelt, et al.
Ebiomedicine|February 13, 2022
Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and PharmacodynamicsTom M Quinn, Erin E Gaughan, Annya Bruce, et al.
Nature Medicine|June 17, 2022
Redefining critical illnessDavid M Maslove, Benjamin Tang, Manu Shankar-Hari, et al.
Critical Care (London, England)|March 17, 2021
Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi methodPrashant Nasa, Elie Azoulay, Ashish K Khanna, et al.
Nature Medicine|September 10, 2020
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosisAdam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, et al.
Pageof 20